Log in to your Inderes Free account to see all free content on this page.
I-tech
53.80 SEK
-0.19 %
Less than 1K followers
ITECH
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Income statement
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for I-tech
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Revenue | 45.6 | 52.8 | 52.9 | 83.6 | 120.9 | 179.5 | 168.1 |
| growth-% | 15.9 % | 0.2 % | 58.1 % | 44.5 % | 48.5 % | -6.3 % | |
| EBITDA | 1.2 | 3.6 | 3.2 | 20.1 | 31.4 | 53.7 | 48.5 |
| EBIT | -7.0 | -5.2 | -4.7 | 12.0 | 23.4 | 45.5 | 41.0 |
| Profit before taxes | -7.1 | -6.0 | -3.3 | 13.4 | 25.5 | 49.2 | 41.8 |
| Net income | 8.4 | -4.8 | -2.6 | 10.6 | 20.2 | 39.0 | 33.2 |
| EPS | 0.71 | -0.40 | -0.22 | 0.90 | 1.70 | 3.30 | 2.80 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 1.50 | 1.00 | 1.25 |
| Dividend ratio | 0.0 % | -0.0 % | -0.0 % | 0.0 % | 88.2 % | 30.3 % | 44.6 % |
Login required
This content is only available for logged in users
Profitability and return on capital
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| EBITDA-% | 2.7 % | 6.8 % | 6.1 % | 24.0 % | 26.0 % | 29.9 % | 28.8 % |
| EBIT-% | -15.4 % | -9.8 % | -8.9 % | 14.4 % | 19.4 % | 25.3 % | 24.4 % |
| ROE | 7.6 % | -4.5 % | -2.5 % | 9.2 % | 14.8 % | 24.8 % | 19.0 % |
| ROI | 6.4 % | -4.0 % | -2.3 % | 8.5 % | 13.3 % | 22.5 % | 17.1 % |
Login required
This content is only available for logged in users